Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2024-12-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/10/6/00188-2024.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841537019537260544 |
|---|---|
| author | Michael E. Wechsler Linda Rogers G. Walter Canonica Arnaud Bourdin Arman Altincatal Megan Hardin Xavier Soler Paul J. Rowe Yamo Deniz Harry Sacks Juby A. Jacob-Nara |
| author_facet | Michael E. Wechsler Linda Rogers G. Walter Canonica Arnaud Bourdin Arman Altincatal Megan Hardin Xavier Soler Paul J. Rowe Yamo Deniz Harry Sacks Juby A. Jacob-Nara |
| author_sort | Michael E. Wechsler |
| collection | DOAJ |
| format | Article |
| id | doaj-art-3db2db5e975449dd93aa3830167d3f50 |
| institution | Kabale University |
| issn | 2312-0541 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | European Respiratory Society |
| record_format | Article |
| series | ERJ Open Research |
| spelling | doaj-art-3db2db5e975449dd93aa3830167d3f502025-01-14T09:50:22ZengEuropean Respiratory SocietyERJ Open Research2312-05412024-12-0110610.1183/23120541.00188-202400188-2024Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristicsMichael E. Wechsler0Linda Rogers1G. Walter Canonica2Arnaud Bourdin3Arman Altincatal4Megan Hardin5Xavier Soler6Paul J. Rowe7Yamo Deniz8Harry Sacks9Juby A. Jacob-Nara10 Department of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA Icahn School of Medicine at Mount Sinai, New York, NY, USA Department of Biomedical Sciences, Humanitas University, Milan, Italy Department of Respiratory Diseases, University of Montpellier, Montpellier, France Sanofi, Cambridge, MA, USA Sanofi, Cambridge, MA, USA Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA Sanofi, Bridgewater, NJ, USA Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA Sanofi, Bridgewater, NJ, USA http://openres.ersjournals.com/content/10/6/00188-2024.full |
| spellingShingle | Michael E. Wechsler Linda Rogers G. Walter Canonica Arnaud Bourdin Arman Altincatal Megan Hardin Xavier Soler Paul J. Rowe Yamo Deniz Harry Sacks Juby A. Jacob-Nara Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics ERJ Open Research |
| title | Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics |
| title_full | Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics |
| title_fullStr | Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics |
| title_full_unstemmed | Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics |
| title_short | Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics |
| title_sort | long term dupilumab efficacy in type 2 asthma regardless of baseline characteristics |
| url | http://openres.ersjournals.com/content/10/6/00188-2024.full |
| work_keys_str_mv | AT michaelewechsler longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT lindarogers longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT gwaltercanonica longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT arnaudbourdin longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT armanaltincatal longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT meganhardin longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT xaviersoler longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT pauljrowe longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT yamodeniz longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT harrysacks longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics AT jubyajacobnara longtermdupilumabefficacyintype2asthmaregardlessofbaselinecharacteristics |